SLC22A4 and cancer: A recent report published in Cancer Research claimed that the ergothioneine transporter (ETT; obsolete name OCTN1) would transport nucleosides and nucleoside analogues with the highest efficiency and, thus, represent an important novel nucleoside transporter [8].